Ventas, Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
On July 2, 2026, Ventas, Inc. amended its limited partnership agreement for Ventas Realty, LP, shifting 99% economic interest from General Partner (Ventas Inc.) to Limited Partner (Ventas OP, LLC), while Ventas Inc. retains non-economic GP rights. Separately, Peter J. Bulgarelli, EVP of Outpatient Medical/Research and CEO of Lillibridge Healthcare, retired May 1, 2026, receiving a prorated 2026 incentive of $324,134 in exchange for a broad release of claims and continued compliance with restrictive covenants.
Why this rating
LP restructuring is internal/technical (no asset transfer, maintains REIT compliance). $324K separation for retiring executive is routine; immaterial relative to $28.6B market cap (~0.001%). Both are standard corporate housekeeping.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.